If you run multiple pipelines, you will get multiple partially overlapping, partially different results. I think it is better to decide a priory on one pipeline, study and understand this pipeline as much as possible, and stick to it. Testing many pipelines and comparing them can (even involuntarily) lead to fishing expeditions, where one chooses the pipeline with the "most interesting" results.
Great point. I am planning to combine the results from multiple-pipelines rather than "choosing the interesting results" from a specific pipeline
For mouse, there is no point in running Trinity or other de novo transcriptome assembler, as the genome assembly and annotation is very good. Transcriptome-based Salmon or kallisto quantification is really fast, so it would be my preferred choice, but you still have to decide which software to use for differential expression, and whether perform differential gene expression or differential transcript expression (differential transcript expression requires more reads per sample than differential gene expression).
I understand the mouse genome is well annotated but some papers highlighted the importance of assembly approaches even when a reference genome is available. This would definitely give a diverse set of results and I am happy to explore the differences between pipelines. I am under the impression though that a multi-pipeline approach would give me a wider net to start with.
You should not use Bowtie2 to map RNAseq to the reference genome - it can be used to map to the reference transcriptome, though, and then one can use RSEM or Salmon for quantification.
Agree. I would prefer using STAR with a reference genome.